These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16978090)

  • 1. Immunostimulatory PyNTTTTGT oligodeoxynucleotides: structural properties and refinement of the active motif.
    Rodriguez JM; Elías F; Fló J; López RA; Zorzopulos J; Montaner AD
    Oligonucleotides; 2006; 16(3):275-85. PubMed ID: 16978090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strong cytosine-guanosine-independent immunostimulation in humans and other primates by synthetic oligodeoxynucleotides with PyNTTTTGT motifs.
    Elias F; Flo J; Lopez RA; Zorzopulos J; Montaner A; Rodriguez JM
    J Immunol; 2003 Oct; 171(7):3697-704. PubMed ID: 14500668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions.
    Marshall JD; Fearon K; Abbate C; Subramanian S; Yee P; Gregorio J; Coffman RL; Van Nest G
    J Leukoc Biol; 2003 Jun; 73(6):781-92. PubMed ID: 12773511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and immunostimulatory properties of Y-shaped DNA consisting of phosphodiester and phosphorothioate oligodeoxynucleotides.
    Matsuoka N; Nishikawa M; Mohri K; Rattanakiat S; Takakura Y
    J Control Release; 2010 Dec; 148(3):311-6. PubMed ID: 20887761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LL-37 promotes rapid sensing of CpG oligodeoxynucleotides by B lymphocytes and plasmacytoid dendritic cells.
    Hurtado P; Peh CA
    J Immunol; 2010 Feb; 184(3):1425-35. PubMed ID: 20042575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a hexameric deoxyriboguanosine run conjugation into CpG oligodeoxynucleotides on their immunostimulatory potentials.
    Lee SW; Song MK; Baek KH; Park Y; Kim JK; Lee CH; Cheong HK; Cheong C; Sung YC
    J Immunol; 2000 Oct; 165(7):3631-9. PubMed ID: 11034366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9.
    Pohar J; Lainšček D; Kunšek A; Cajnko MM; Jerala R; Benčina M
    Sci Rep; 2017 Nov; 7(1):14598. PubMed ID: 29097808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
    Gekeler V; Gimmnich P; Hofmann HP; Grebe C; Römmele M; Leja A; Baudler M; Benimetskaya L; Gonser B; Pieles U; Maier T; Wagner T; Sanders K; Beck JF; Hanauer G; Stein CA
    Oligonucleotides; 2006; 16(1):83-93. PubMed ID: 16584297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system.
    Hanagata N
    Int J Nanomedicine; 2012; 7():2181-95. PubMed ID: 22619554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel immunostimulatory phosphodiester oligodeoxynucleotides with CpT sequences instead of CpG motifs.
    Kim D; Jung J; Lee Y; Kwon HJ
    Mol Immunol; 2011 Jul; 48(12-13):1494-504. PubMed ID: 21529949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes.
    Vollmer J; Janosch A; Laucht M; Ballas ZK; Schetter C; Krieg AM
    Antisense Nucleic Acid Drug Dev; 2002 Jun; 12(3):165-75. PubMed ID: 12162699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirements for effective inhibition of immunostimulatory CpG motifs by neutralizing motifs.
    Zhao H; Cheng SH; Yew NS
    Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):381-9. PubMed ID: 11079577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.
    Hartmann G; Battiany J; Poeck H; Wagner M; Kerkmann M; Lubenow N; Rothenfusser S; Endres S
    Eur J Immunol; 2003 Jun; 33(6):1633-41. PubMed ID: 12778481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists.
    Meng W; Yamazaki T; Nishida Y; Hanagata N
    BMC Biotechnol; 2011 Sep; 11():88. PubMed ID: 21943407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets.
    Linghua Z; Xingshan T; Fengzhen Z
    Vaccine; 2008 Jan; 26(2):224-33. PubMed ID: 18063448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG oligonucleotides.
    Zwiorek K; Bourquin C; Battiany J; Winter G; Endres S; Hartmann G; Coester C
    Pharm Res; 2008 Mar; 25(3):551-62. PubMed ID: 17912489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorothioate oligodeoxyribonucleotides induce in vitro proliferation of chicken B-cells.
    Wattrang E
    Vet Immunol Immunopathol; 2009 Oct; 131(3-4):218-28. PubMed ID: 19447503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif.
    Zhang Y; Shoda LK; Brayton KA; Estes DM; Palmer GH; Brown WC
    J Interferon Cytokine Res; 2001 Oct; 21(10):871-81. PubMed ID: 11711000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
    Vollmer J; Weeratna RD; Jurk M; Samulowitz U; McCluskie MJ; Payette P; Davis HL; Schetter C; Krieg AM
    Immunology; 2004 Oct; 113(2):212-23. PubMed ID: 15379982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.
    Ballas ZK; Rasmussen WL; Krieg AM
    J Immunol; 1996 Sep; 157(5):1840-5. PubMed ID: 8757300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.